Suppr超能文献

非小细胞肺癌中p63、角蛋白5/6、角蛋白7和表面活性蛋白A的表达

Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas.

作者信息

Camilo Ricardo, Capelozzi Vera Luíza, Siqueira Sheila Aparecida Coelho, Del Carlo Bernardi Fabíola

机构信息

Department of Pathology, São Paulo University Medical School, São Paulo, SP, Brazil.

出版信息

Hum Pathol. 2006 May;37(5):542-6. doi: 10.1016/j.humpath.2005.12.019.

Abstract

In this study, we sought to validate the importance of p63, CK5/CK6, CK7, and surfactant-A (SP-A) to classify 42 non-small cell lung cancers in autopsy and surgical resection specimens and to study the usefulness of these markers in distinguishing between squamous cell carcinomas and adenocarcinomas because of their different implications regarding treatment and prognosis. All adenocarcinoma cases were negative for p63; 9 (56.2%) of 16 were CK5/CK6 positive, 16 (94.1%) of 17 were CK7 positive, and 4 (26.6%) of 15 were SP-A positive. In squamous cell carcinoma, 1 case was CK7 and SP-A positive and 14 (77.8%) of 18 were p63 positive. The latter appears to be useful in differentiating squamous cell carcinoma from adenocarcinoma of the lung in small biopsies without keratinization or glandular differentiation; thus, for advanced-stage cases, where there is no possibility of surgical resection and the treatment of choice is radiotherapy plus chemotherapy, we would be able to differentiate between the two histological types, establishing then a different therapy.

摘要

在本研究中,我们试图验证p63、细胞角蛋白5/细胞角蛋白6(CK5/CK6)、细胞角蛋白7(CK7)和表面活性蛋白A(SP-A)在对42例非小细胞肺癌尸检和手术切除标本进行分类中的重要性,并研究这些标志物在区分鳞状细胞癌和腺癌方面的有用性,因为它们在治疗和预后方面具有不同的意义。所有腺癌病例p63均为阴性;16例中有9例(56.2%)CK5/CK6阳性,17例中有16例(94.1%)CK7阳性,15例中有4例(26.6%)SP-A阳性。在鳞状细胞癌中,1例CK7和SP-A阳性,18例中有14例(77.8%)p63阳性。后者似乎有助于在无角化或腺分化的小活检中区分肺鳞状细胞癌和腺癌;因此,对于无法进行手术切除且首选治疗为放疗加化疗的晚期病例,我们能够区分这两种组织学类型,从而制定不同的治疗方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验